Evidence map›Paper›PMID 41748596›Full record

ArticleNature communications2026

Author Correction: H3.3 deposition counteracts the replication-dependent enrichment of H3.1 at chromocenters in embryonic stem cells.

Stefano Arfè, Tina Karagyozova, Audrey Forest, Dominic Bingham, Hatem Hmidan, David Mazaud, Mickaël Garnier, Patricia Le Baccon, Eran Meshorer, Jean-Pierre Quivy and 1 more

Abstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in Nature communications, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

11 authors.

Stefano ArfèNuclear Dynamics, Institut Curie, PSL University, Sorbonne Université, CNRS, Paris, France.ORCID http://orcid.org/0000-0002-1514-6366
Tina KaragyozovaNuclear Dynamics, Institut Curie, PSL University, Sorbonne Université, CNRS, Paris, France.ORCID http://orcid.org/0000-0002-5923-5678
Audrey ForestNuclear Dynamics, Institut Curie, PSL University, Sorbonne Université, CNRS, Paris, France.
Dominic BinghamNuclear Dynamics, Institut Curie, PSL University, Sorbonne Université, CNRS, Paris, France.ORCID http://orcid.org/0009-0001-8831-5175
Hatem HmidanNuclear Dynamics, Institut Curie, PSL University, Sorbonne Université, CNRS, Paris, France.
David MazaudNuclear Dynamics, Institut Curie, PSL University, Sorbonne Université, CNRS, Paris, France.ORCID http://orcid.org/0000-0003-3998-9330
Mickaël GarnierNuclear Dynamics, Institut Curie, PSL University, Sorbonne Université, CNRS, Paris, France.ORCID http://orcid.org/0000-0002-3999-0879
Patricia Le BacconNuclear Dynamics, Institut Curie, PSL University, Sorbonne Université, CNRS, Paris, France.ORCID http://orcid.org/0000-0001-8650-4995
Eran MeshorerDepartment of Genetics, The Alexander Silberman Institute for Life Science, and the Edmond and Lily Safra Center for Brain Sciences (ELSC), The Hebrew University of Jerusalem, Jerusalem, Israel.ORCID http://orcid.org/0000-0003-4777-986X
Jean-Pierre QuivyNuclear Dynamics, Institut Curie, PSL University, Sorbonne Université, CNRS, Paris, France. jean-pierre.quivy@curie.fr.ORCID http://orcid.org/0000-0001-6557-7204
Geneviève AlmouzniNuclear Dynamics, Institut Curie, PSL University, Sorbonne Université, CNRS, Paris, France. Genevieve.almouzni@curie.fr.ORCID http://orcid.org/0000-0001-5570-0723

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID41748596
PMCPMC12946263

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.